Arrhythmias in Cardiac Sarcoidosis: Management and Prognostic Implications

Overview

Journal J Clin Med

Specialty General Medicine

Date 2024 Jun 19

PMID 38892878

Authors

Suganya Arunachalam Karikalan

Ali Yusuf

Hicham El Masry

Affiliations

Soon will be listed here.

Abstract

Cardiac sarcoidosis (CS) is characterized by various arrhythmic manifestations ranging from catastrophic sudden cardiac death secondary to ventricular arrhythmia, severe conduction disease, sinus node dysfunction, and atrial fibrillation. The management of CS is complex and includes not only addressing the arrhythmia but also controlling the myocardial inflammation resultant from the autoimmune reaction. Arrhythmic manifestations of CS carry significant prognostic implications and invariably affect long-term survival in these patients. In this review, we focus on management of arrhythmic manifestation of cardiac sarcoidosis as well as risk stratification for sudden cardiac death in these patients.

Citing Articles

Outcomes of catheter ablation in cardiac sarcoidosis patients with ventricular tachycardia: a propensity score-matched retrospective analysis.

Al Taii H, Saxena R, Morcos R, Al-Shammari A, Farhat K, Al Sakini A J Interv Card Electrophysiol. 2025; .

PMID: 39786700 DOI: 10.1007/s10840-025-01986-0.

Contemporary Diagnostics of Cardiac Sarcoidosis: The Importance of Multimodality Imaging.

Stjepanovic M, Markovic F, Milivojevic I, Popevic S, Dimic-Janjic S, Popadic V Diagnostics (Basel). 2024; 14(17).

PMID: 39272650 PMC: 11394254. DOI: 10.3390/diagnostics14171865.

References

Haanschoten D, Adiyaman A, t Hart N, Jager P, Elvan A . Value of 3D mapping-guided endomyocardial biopsy in cardiac sarcoidosis: Case series and narrative review on the value of electro-anatomic mapping-guided endomyocardial biopsies. Eur J Clin Invest. 2021; 51(4):e13497. DOI: 10.1111/eci.13497. View

Slaughter M, Rogers J, Milano C, Russell S, Conte J, Feldman D . Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009; 361(23):2241-51. DOI: 10.1056/NEJMoa0909938. View

Ezzeddine F, Kapa S, Rosenbaum A, Blauwet L, Deshmukh A, AbouEzzeddine O . Electrogram-guided endomyocardial biopsy yield in patients with suspected cardiac sarcoidosis and relation to outcomes. J Cardiovasc Electrophysiol. 2021; 32(9):2486-2495. DOI: 10.1111/jce.15191. View

Nakajo M, Hirahara D, Jinguji M, Ojima S, Hirahara M, Tani A . Machine learning approach using F-FDG-PET-radiomic features and the visibility of right ventricle F-FDG uptake for predicting clinical events in patients with cardiac sarcoidosis. Jpn J Radiol. 2024; 42(7):744-752. PMC: 11217075. DOI: 10.1007/s11604-024-01546-y. View

Nordenswan H, Poyhonen P, Lehtonen J, Ekstrom K, Uusitalo V, Niemela M . Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator. Circulation. 2022; 146(13):964-975. PMC: 9508990. DOI: 10.1161/CIRCULATIONAHA.121.058120. View

Flautt T, Lador A, Da-Wariboko A, Schwartz M, Valderrabano M . PET-Driven, Voltage-Guided Atrial Endomyocardial Biopsy Clinches the Diagnosis of Cardiac Sarcoidosis. JACC Case Rep. 2021; 3(16):1764-1768. PMC: 8603053. DOI: 10.1016/j.jaccas.2021.08.021. View

Smedema J, Ainslie G, Crijns H . Review: Contrast-enhanced magnetic resonance in the diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis. 2020; 63(3):271-307. DOI: 10.1016/j.pcad.2020.03.011. View

Sink J, Joyce C, Liebo M, Wilber D . Long-Term Outcomes of Cardiac Sarcoid: Prognostic Implications of Isolated Cardiac Involvement and Impact of Diagnostic Delays. J Am Heart Assoc. 2023; 12(19):e028342. PMC: 10727252. DOI: 10.1161/JAHA.122.028342. View

Karameh M, Meir K, Qadan A, Pappo O, Cohen D, Durst R . Endomyocardial biopsy in clinical practice: the diagnostic yield and insights from a 5-year single-center experience. Hellenic J Cardiol. 2024; . DOI: 10.1016/j.hjc.2024.03.004. View

10.

Sohn D, Park J . Cardiac sarcoidosis. Heart. 2023; 109(15):1132-1138. DOI: 10.1136/heartjnl-2022-321379. View

11.

Maizels L, Mansour M, Abu-Much A, Massalha E, Kalstein M, Beinart R . Prevalence of Cardiac Sarcoidosis in Middle-Aged Adults Diagnosed with High-Grade Atrioventricular Block. Am J Med. 2023; 137(4):358-365. DOI: 10.1016/j.amjmed.2023.11.027. View

12.

Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt M, Blankstein R . Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther. 2016; 6(1):50-63. PMC: 4731586. DOI: 10.3978/j.issn.2223-3652.2015.12.13. View

13.

Mohsen A, Jimenez A, Hood R, Dickfeld T, Saliaris A, Shorofsky S . Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator. J Cardiovasc Electrophysiol. 2014; 25(2):171-6. DOI: 10.1111/jce.12302. View

14.

Mehta D, Mori N, Goldbarg S, Lubitz S, Wisnivesky J, Teirstein A . Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol. 2011; 4(1):43-8. DOI: 10.1161/CIRCEP.110.958322. View

15.

Ribeiro Neto M, Jellis C, Cremer P, Harper L, Taimeh Z, Culver D . Cardiac Sarcoidosis. Clin Chest Med. 2024; 45(1):105-118. DOI: 10.1016/j.ccm.2023.08.006. View

16.

Adhaduk M, Paudel B, Liu K, Ashwath M, Giudici M . Meta-Analysis of Catheter Ablation Outcomes in Patients With Cardiac Sarcoidosis Refractory Ventricular Tachycardia. Am J Cardiol. 2022; 174:136-142. DOI: 10.1016/j.amjcard.2022.03.038. View

17.

Nakahara M, Takemoto M, Fujishima S, Tsuchihashi T . A case report of recovery of sinus node abnormalities associated with right atrial involvement of 'early-stage' cardiac sarcoidosis. Eur Heart J Case Rep. 2022; 6(12):ytac447. PMC: 9757674. DOI: 10.1093/ehjcr/ytac447. View

18.

Niemela M, Uusitalo V, Poyhonen P, Schildt J, Lehtonen J, Kupari M . Incidence and Predictors of Atrial Fibrillation in Cardiac Sarcoidosis: A Multimodality Imaging Study. JACC Cardiovasc Imaging. 2022; 15(9):1622-1631. DOI: 10.1016/j.jcmg.2022.02.025. View

19.

Rossides M, Darlington P, Kullberg S, Arkema E . Sarcoidosis: Epidemiology and clinical insights. J Intern Med. 2023; 293(6):668-680. DOI: 10.1111/joim.13629. View

20.

Bobbio E, Bjorkenstam M, Nwaru B, Giallauria F, Hessman E, Bergh N . Short- and long-term outcomes after heart transplantation in cardiac sarcoidosis and giant-cell myocarditis: a systematic review and meta-analysis. Clin Res Cardiol. 2021; 111(2):125-140. PMC: 8816313. DOI: 10.1007/s00392-021-01920-0. View